Foreign pharmaceutical companies minimized clinical tests of preparations to Russian Federation

Following the results of the first half of the year 2023 foreign pharmaceutical companies got seven permissions to carrying out clinical tests of new preparations to Russian Federation. About it reported newspaper "Kommersant" with reference to AOKI. According to association calculations, one more permission to clinical tests was got also by the Russian JOINT-STOCK COMPANY "BIOKAD". These indicators are 13,5 times less in comparison with the similar period of last year when Minzdrav gave out 111 such permissions (-27,5% by 2021). According to the newspaper, the only company which got permission...